Previous research on plumbagin inhibition of angiogenesis-mediated tumor growth in HCC has shown (33) that plumbagin inhibits the expression of Ang/Tie2 and has significant antitumor activity, suggesting that plumbagin may be a promising antiangiogenesis drug. Here, ANG is linked to hepatocellular carcinoma.